Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients

BACKGROUND: The treatment of metastatic breast cancer (MBC) remains a great clinical challenge as drug resistance frequently develops. Alternative agents that can overcome drug resistance would offer new therapeutic options. The primary aim of this phase II study was to evaluate the efficacy and saf...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Hematol Oncol
Main Authors: Zhang, Pin, Tong, Zhongsheng, Tian, Fuguo, Wang, Yongsheng, Yang, Junlan, Li, Weilian, Di, Lijun, Liu, Wei, Tang, Li, Qiu, Rongguo, Xu, Binghe
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2016
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982136/
https://ncbi.nlm.nih.gov/pubmed/27516093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0297-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker